PANCDR: precise medicine prediction using an adversarial network for cancer drug response
Briefings in Bioinformatics · 22.01.2024 · 25 (2)
DOI: 10.1093/bib/bbae088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 14.03.2024. Verfasst von Juyeon Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Electrical Engineering and Computer Science, Gwangju Institute of Science and Technology, 61005, Gwangju, South Korea. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Institute of Information & Communications Technology Planning & Evaluation, MSIT, Development of Intelligent SW Systems for Uncovering Genetic Variation and Developing Personalized Medicine for Cancer Patients with Unknown Molecular Genetic….
Abstract (Originalsprache)
Pharmacogenomics aims to provide personalized therapy to patients based on their genetic variability. However, accurate prediction of cancer drug response (CDR) is challenging due to genetic heterogeneity. Since clinical data are limited, most studies predicting drug response use preclinical data to train models. However, such models might not be generalizable to external clinical data due to differences between the preclinical and clinical datasets. In this study, a Precision Medicine Prediction using an Adversarial Network for Cancer Drug Response (PANCDR) model is proposed. PANCDR consists of two sub-models, an adversarial model and a CDR prediction model. The adversarial model reduces the gap between the preclinical and clinical datasets, while the CDR prediction model extracts features and predicts responses. PANCDR was trained using both preclinical data and unlabeled clinical data. Subsequently, it was tested on external clinical data, including The Cancer Genome Atlas and brain tumor patients. PANCDR outperformed other machine learning models in predicting external test data. Our results demonstrate the robustness of PANCDR and its potential in precision medicine by recommending patient-specific drug candidates. The PANCDR codes and data are available at https://github.com/DMCB-GIST/PANCDR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Electrical Engineering and Computer Science, Gwangju Institute of Science and Technology, 61005, Gwangju, South Korea.
- Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 03080, Seoul, South Korea.
- Neuroscience Research Institute, Seoul National University College of Medicine, 03080, Seoul, South Korea.
- Artificial Intelligence Graduate School, Gwangju Institute of Science and Technology, 61005, Gwangju, South Korea.
ORCID-Profile: Hyunju Lee
Förderung
- Institute of Information & Communications Technology Planning & Evaluation
- MSIT
- Development of Intelligent SW Systems for Uncovering Genetic Variation and Developing Personalized Medicine for Cancer Patients with Unknown Molecular Genetic…
- Artificial Intelligence Graduate School Program
- Human Biobank of Seoul National University Hospital
- Korea Biobank Network
- Seoul National University Hospital Cancer Tissue Bank
Zitieren
APA
Kim, J., Park, S. H., & Lee, H. (2024). PANCDR: precise medicine prediction using an adversarial network for cancer drug response. Briefings in Bioinformatics, 25(2). https://doi.org/10.1093/bib/bbae088
Vancouver
Kim J, Park SH, Lee H. PANCDR: precise medicine prediction using an adversarial network for cancer drug response. Briefings in Bioinformatics. 2024;25(2). doi:10.1093/bib/bbae088
BibTeX
@article{Kim2024,
author = {Kim, Juyeon and Park, Sung-Hye and Lee, Hyunju},
title = {PANCDR: precise medicine prediction using an adversarial network for cancer drug response},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {25},
number = {2},
doi = {10.1093/bib/bbae088}
}
EUVIMED